Stoke Therapeutics (STOK) Soars 12.0%: Is Further Upside Left in the Stock?

  • Stoke Therapeutics (STOK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.